請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25240
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳瑞華 | |
dc.contributor.author | Yi-Chien Lee | en |
dc.contributor.author | 李宜蒨 | zh_TW |
dc.date.accessioned | 2021-06-08T06:06:15Z | - |
dc.date.copyright | 2007-08-08 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-23 | |
dc.identifier.citation | Reference
Adams, J., Kelso, R., and Cooley, L. (2000). The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 10, 17-24. Angers, S., Li, T., Yi, X., MacCoss, M. J., Moon, R. T., and Zheng, N. (2006). Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 443, 590-593. Aravind, L., and Koonin, E. V. (1999). Fold prediction and evolutionary analysis of the POZ domain: structural and evolutionary relationship with the potassium channel tetramerization domain. J Mol Biol 285, 1353-1361. Baba, D., Maita, N., Jee, J. G., Uchimura, Y., Saitoh, H., Sugasawa, K., Hanaoka, F., Tochio, H., Hiroaki, H., and Shirakawa, M. (2005). Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature 435, 979-982. Bardwell, V. J., and Treisman, R. (1994). The POZ domain: a conserved protein-protein interaction motif. Genes Dev 8, 1664-1677. Barna, M., Merghoub, T., Costoya, J. A., Ruggero, D., Branford, M., Bergia, A., Samori, B., and Pandolfi, P. P. (2002). Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev Cell 3, 499-510. Bohren, K. M., Nadkarni, V., Song, J. H., Gabbay, K. H., and Owerbach, D. (2004). A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 279, 27233-27238. Choe, S., Cushman, S., Baker, K. A., and Pfaffinger, P. (2002). Excitability is mediated by the T1 domain of the voltage-gated potassium channel. Novartis Found Symp 245, 169-175; discussion 175-167, 261-164. Comerford, K. M., Leonard, M. O., Karhausen, J., Carey, R., Colgan, S. P., and Taylor, C. T. (2003). Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci U S A 100, 986-991. d'Azzo, A., Bongiovanni, A., and Nastasi, T. (2005). E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 6, 429-441. Dai, Q., and Wang, H. (2006). 'Cullin 4 makes its mark on chromatin'. Cell Div 1, 14. Deshaies, R. J. (1999). SCF and Cullin/Ring H2-based ubiquitin ligases. Annu Rev Cell Dev Biol 15, 435-467. Desterro, J. M., Rodriguez, M. S., and Hay, R. T. (1998). SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2, 233-239. Desterro, J. M., Rodriguez, M. S., Kemp, G. D., and Hay, R. T. (1999). Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J Biol Chem 274, 10618-10624. Desterro, J. M., Thomson, J., and Hay, R. T. (1997). Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett 417, 297-300. Dohmen, R. J. (2004). SUMO protein modification. Biochim Biophys Acta 1695, 113-131. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R., and Orr, A. (1999). Cell cycle regulation of PML modification and ND10 composition. J Cell Sci 112 ( Pt 24), 4581-4588. Gill, G. (2004). SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 18, 2046-2059. Girdwood, D., Bumpass, D., Vaughan, O. A., Thain, A., Anderson, L. A., Snowden, A. W., Garcia-Wilson, E., Perkins, N. D., and Hay, R. T. (2003). P300 transcriptional repression is mediated by SUMO modification. Mol Cell 11, 1043-1054. Glickman, M. H., and Ciechanover, A. (2002). The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82, 373-428. Hara, T., Ishida, H., Raziuddin, R., Dorkhom, S., Kamijo, K., and Miki, T. (2004). Novel kelch-like protein, KLEIP, is involved in actin assembly at cell-cell contact sites of Madin-Darby canine kidney cells. Mol Biol Cell 15, 1172-1184. Harper, J. W., Burton, J. L., and Solomon, M. J. (2002). The anaphase-promoting complex: it's not just for mitosis any more. Genes Dev 16, 2179-2206. Hay, R. T. (2004). Modifying NEMO. Nat Cell Biol 6, 89-91. Hay, R. T. (2005). SUMO: a history of modification. Mol Cell 18, 1-12. He, Y. J., McCall, C. M., Hu, J., Zeng, Y., and Xiong, Y. (2006). DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases. Genes Dev 20, 2949-2954. Hecker, C. M., Rabiller, M., Haglund, K., Bayer, P., and Dikic, I. (2006). Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem 281, 16117-16127. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu Rev Biochem 67, 425-479. Hicke, L. (2001). Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2, 195-201. Hietakangas, V., Ahlskog, J. K., Jakobsson, A. M., Hellesuo, M., Sahlberg, N. M., Holmberg, C. I., Mikhailov, A., Palvimo, J. J., Pirkkala, L., and Sistonen, L. (2003). Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol 23, 2953-2968. Higa, L. A., and Zhang, H. (2007). Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy. Cell Div 2, 5. Hilgarth, R. S., Hong, Y., Park-Sarge, O. K., and Sarge, K. D. (2003). Insights into the regulation of heat shock transcription factor 1 SUMO-1 modification. Biochem Biophys Res Commun 303, 196-200. Hilgarth, R. S., Murphy, L. A., Skaggs, H. S., Wilkerson, D. C., Xing, H., and Sarge, K. D. (2004). Regulation and function of SUMO modification. J Biol Chem 279, 53899-53902. Hochstrasser, M. (2001). SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell 107, 5-8. Hoege, C., Pfander, B., Moldovan, G. L., Pyrowolakis, G., and Jentsch, S. (2002). RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135-141. Hsuan-Chung Ho. (2004). A novel BTB-kelch protein DIP2 promotes DAPK degradation through Cul3 ubiquitination ligase complex. Master Thesis. Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472. Johnson, E. S. (2004). Protein modification by SUMO. Annu Rev Biochem 73, 355-382. Kagey, M. H., Melhuish, T. A., and Wotton, D. (2003). The polycomb protein Pc2 is a SUMO E3. Cell 113, 127-137. Kaiser, P., Flick, K., Wittenberg, C., and Reed, S. I. (2000). Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4. Cell 102, 303-314. Kerscher, O. (2007). SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep 8, 550-555. Kile, B. T., Schulman, B. A., Alexander, W. S., Nicola, N. A., Martin, H. M., and Hilton, D. J. (2002). The SOCS box: a tale of destruction and degradation. Trends Biochem Sci 27, 235-241. Kirsh, O., Seeler, J. S., Pichler, A., Gast, A., Muller, S., Miska, E., Mathieu, M., Harel-Bellan, A., Kouzarides, T., Melchior, F., and Dejean, A. (2002). The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. Embo J 21, 2682-2691. Koonin, E. V., Senkevich, T. G., and Chernos, V. I. (1992). A family of DNA virus genes that consists of fused portions of unrelated cellular genes. Trends Biochem Sci 17, 213-214. Kurepa, J., Walker, J. M., Smalle, J., Gosink, M. M., Davis, S. J., Durham, T. L., Sung, D. Y., and Vierstra, R. D. (2003). The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis. Accumulation of SUMO1 and -2 conjugates is increased by stress. J Biol Chem 278, 6862-6872. Lee, Y. J., Miyake, S., Wakita, H., McMullen, D. C., Azuma, Y., Auh, S., and Hallenbeck, J. M. (2007). Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J Cereb Blood Flow Metab 27, 950-962. Li, S. J., and Hochstrasser, M. (2000). The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol Cell Biol 20, 2367-2377. Lin, D. Y., Huang, Y. S., Jeng, J. C., Kuo, H. Y., Chang, C. C., Chao, T. T., Ho, C. C., Chen, Y. C., Lin, T. P., Fang, H. I., et al. (2006). Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell 24, 341-354. Lin, X., Sun, B., Liang, M., Liang, Y. Y., Gast, A., Hildebrand, J., Brunicardi, F. C., Melchior, F., and Feng, X. H. (2003). Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell 11, 1389-1396. Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. (1997). A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107. Matunis, M. J., Zhang, X. D., and Ellis, N. A. (2006). SUMO: the glue that binds. Dev Cell 11, 596-597. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe, P. J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275. Melchior, F., Schergaut, M., and Pichler, A. (2003). SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem Sci 28, 612-618. Muller, S., Berger, M., Lehembre, F., Seeler, J. S., Haupt, Y., and Dejean, A. (2000). c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 275, 13321-13329. Nacak, T. G., Alajati, A., Leptien, K., Fulda, C., Weber, H., Miki, T., Czepluch, F. S., Waltenberger, J., Wieland, T., Augustin, H. G., and Kroll, J. (2007). The BTB-Kelch protein KLEIP controls endothelial migration and sprouting angiogenesis. Circ Res 100, 1155-1163. Nelson, D. A., Tan, T. T., Rabson, A. B., Anderson, D., Degenhardt, K., and White, E. (2004). Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes Dev 18, 2095-2107. Nguyen, H. V., Chen, J. L., Zhong, J., Kim, K. J., Crandall, E. D., Borok, Z., Chen, Y., and Ann, D. K. (2006). SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells. Am J Pathol 168, 1452-1463. Perez-Torrado, R., Yamada, D., and Defossez, P. A. (2006). Born to bind: the BTB protein-protein interaction domain. Bioessays 28, 1194-1202. Petroski, M. D., and Deshaies, R. J. (2005). Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6, 9-20. Pichler, A., Gast, A., Seeler, J. S., Dejean, A., and Melchior, F. (2002). The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109-120. Pintard, L., Willems, A., and Peter, M. (2004). Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. Embo J 23, 1681-1687. Prag, S., and Adams, J. C. (2003). Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals. BMC Bioinformatics 4, 42. Rodriguez, M. S., Dargemont, C., and Hay, R. T. (2001). SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 276, 12654-12659. Saitoh, H., and Hinchey, J. (2000). Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 275, 6252-6258. Salomoni, P., and Pandolfi, P. P. (2002). The role of PML in tumor suppression. Cell 108, 165-170. Sapetschnig, A., Rischitor, G., Braun, H., Doll, A., Schergaut, M., Melchior, F., and Suske, G. (2002). Transcription factor Sp3 is silenced through SUMO modification by PIAS1. Embo J 21, 5206-5215. Scheffner, M., Nuber, U., and Huibregtse, J. M. (1995). Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373, 81-83. Sharma, M., Li, X., Wang, Y., Zarnegar, M., Huang, C. Y., Palvimo, J. J., Lim, B., and Sun, Z. (2003). hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. Embo J 22, 6101-6114. Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M., and Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol Cell 24, 331-339. Stogios, P. J., Downs, G. S., Jauhal, J. J., Nandra, S. K., and Prive, G. G. (2005). Sequence and structural analysis of BTB domain proteins. Genome Biol 6, R82. Stogios, P. J., and Prive, G. G. (2004). The BACK domain in BTB-kelch proteins. Trends Biochem Sci 29, 634-637. Takahashi, Y., Mizoi, J., Toh, E. A., and Kikuchi, Y. (2000). Yeast Ulp1, an Smt3-specific protease, associates with nucleoporins. J Biochem (Tokyo) 128, 723-725. Takahashi, Y., Toh-e, A., and Kikuchi, Y. (2001). A novel factor required for the SUMO1/Smt3 conjugation of yeast septins. Gene 275, 223-231. Tatham, M. H., Kim, S., Jaffray, E., Song, J., Chen, Y., and Hay, R. T. (2005). Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat Struct Mol Biol 12, 67-74. Verma, R., Annan, R. S., Huddleston, M. J., Carr, S. A., Reynard, G., and Deshaies, R. J. (1997). Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase. Science 278, 455-460. Xu, L., Wei, Y., Reboul, J., Vaglio, P., Shin, T. H., Vidal, M., Elledge, S. J., and Harper, J. W. (2003). BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 425, 316-321. Xue, F., and Cooley, L. (1993). kelch encodes a component of intercellular bridges in Drosophila egg chambers. Cell 72, 681-693. Zheng, N., Wang, P., Jeffrey, P. D., and Pavletich, N. P. (2000). Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A., and Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752. Zipper, L. M., and Mulcahy, R. T. (2002). The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J Biol Chem 277, 36544-36552. Zollman, S., Godt, D., Prive, G. G., Couderc, J. L., and Laski, F. A. (1994). The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc Natl Acad Sci U S A 91, 10717-10721. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25240 | - |
dc.description.abstract | BTB-kelch蛋白KLEIP (Kelch-like ECT2 interacting protein),為一個大小64 kDa的蛋白。其蛋白質結構中包含了一個BTB/POZ區塊,一個BACK區塊,以及六個kelch重複片段。在本實驗室先前的研究中,我們用死亡相關激酶 (DAPK)之死亡區塊進行酵母菌雙雜合系統分析,發現KLEIP為其交互作用蛋白。進一步的實驗發現,KLEIP的功能在於作為Cul3泛素連接酶複合體作用時的受質辨認者,KLEIP對DAPK做專一性的辨認之後,透過這樣的複合體對DAPK進行泛素化修飾,進而使DAPK被送至蛋白酶體降解。在本篇論文中,我們發現KLEIP在不同的細胞株及不同的人類組織中均有表現。此外,利用Triton生化萃取分析,發現KLEIP分布在細胞中Triton無法溶解的部份。在此之後,我們更進一步證明細胞中內生的KLEIP以及Cul3與BTB蛋白交互作用的能力皆在DAPK泛素化扮演不可或缺的角色,證實了DAPK為KLEIP/Cul3/Roc1泛素連接酶複合體之受質。另外,我們進一步探究是否KLEIP本身會被轉譯後修飾及調控。參考以酵母菌雙雜合系統預測KLEIP之交互蛋白與KLEIP蛋白質序列分析結果,我們推測KLEIP 會進行類泛素化修飾。之後我們證明了KLEIP的確會進行類泛素化修飾,且這個修飾在缺氧環境下會受到正向調控。此外,我們也發現了KLEIP還會與SUMO1有非共價之交互作用。綜合以上結果,我們發現了KLEIP的轉譯後類泛素修飾以及其與SUMO1之非共價交互作用能力,並且推測這兩種特性可能會調節KLEIP之功能或其在細胞內之位置,進而影響DAPK之泛素化修飾。 | zh_TW |
dc.description.abstract | The BTB-kelch protein KLEIP (Kelch-like ECT2 interacting protein) is a 64 kDa protein which contains a BTB/POZ domain, a BACK domain, and six kelch repeats. Previous study in our laboratory identified KLEIP as a binding partner of DAPK (Death -associated protein kinase) and revealed a function of KLEIP as the substrate adaptor of Cul3 ubiquitin E3 ligase complex to promote DAPK ubiquitination and proteasomal degradation. In this thesis, we first found that KLEIP was ubiquitously expressed in various tissues and cell lines and present in detergent insoluble compartment of cells. We also demonstrated the essential roles of endogenous KLEIP and the KLEIP binding ability of Cul3 to promote DAPK ubiquitination, further confirming DAPK as a substrate of KLEIP/Cul3/Roc1 E3 ligase complex. In addition, we explored whether the substrate adaptor KLEIP itself would be modified and/or regulated. Based on the results of yeast two-hybrid screen for putative KLEIP-interacting proteins and sequence analysis of KLEIP protein, we postulated that KLEIP may undergo SUMO modification. Indeed, we demonstrated that KLEIP was sumoylated in vivo, and this modification was up-regulated under hypoxia conditions. Furthermore, we found that KLEIP can bind SUMO1 non-covalently through its consensus SUMO interacting motifs (SIMs). Together, we revealed the post-translational SUMO modification and SUMO1-binding ability of KLEIP, and we speculated that sumoylation and SUMO1-interaction of KLEIP may regulate its function and/or subcellular localization to influence the ubiquitination of DAPK. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T06:06:15Z (GMT). No. of bitstreams: 1 ntu-96-R94448004-1.pdf: 1808029 bytes, checksum: 5266489c608c859a082505fbab9b4124 (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | Table of Content
中文摘要 4 Abstract 5 Introduction 6 Ubiquitination 6 BTB proteins 9 SUMOylation 12 KLEIP 18 Materials and Methods 19 Cell culture and transient transfection 19 Plasmid 19 Antibodies and reagents 20 Western blotting 20 In vivo ubiquitination assay 20 In vivo sumoylation assay 21 Detergent extraction assay 21 RT-PCR 22 Lentivirus production 22 Results 24 KLEIP mRNA is ubiquitously expressed in various human cell lines and tissues 24 Endogenous KLEIP is present in the detergent-insoluble fraction in cells 24 The BTB-binding ability of Cul3 is required for Cul3-KLEIP-mediated DAPK ubiquitination 25 Establishment of KLEIP knockdown cell lines 25 KLEIP is required for ubiquitination of DAPK in vivo 26 KLEIP is sumoylated in vivo 27 Lys 278 residue in KLEIP is crucial for SUMO-1 modification of KLEIP 28 The sumoylation of KLEIP is up-regulated under hypoxia conditions 28 KLEIP associates with SUMO1 in vivo 29 IIe34 residue in SUMO1 is important for the non-covalent binding between KLEIP and SUMO1 30 KLEIP interacts with SUMO1 through its conserved SIMs. 30 Discussion 32 Reference 38 Figures 46 Figure 1. KLEIP mRNA expression in different human cell lines. 46 Figure 2. KLEIP mRNA expression of in different human tissues. 47 Figure 3. Endogenous KLEIP is part of the detergent-insoluble fraction in cells. 48 Figure 4. The BTB-binding mutants of Cul3 cannot efficiently bind KLEIP and promote DAPK ubiquitination. 49 Figure 5. Establish the KLEIP knockdown cell lines. 50 Figure 6. KLEIP knockdown attenuates the ubiquitination of DAPK in vivo. 51 Figure 7. KLEIP can be sumoylated in vivo. 52 Figure 8. KLEIP K278R mutant is less sumoylated in vivo. 53 Figure 9. The sumoylation of KLEIP is not affected in KLEIPK49R mutant. 54 Figure 10. Endogenous KLEIP protein level is not changed under hypoxia conditions. 55 Figure 11. KLEIP sumoylation is apparently increased under hypoxia conditions. 56 Figure 12. KLEIP can bind SUMO1 non-covalently. 57 Figure 13. KLEIP interacts with SUMO1 through its conserved SUMO interacting motifs. 58 Appendix 59 Figure S1. KLEIP can be sumoylated in vivo. 59 Figure S2. The non-covalent binding between KLEIP and SUMO1 is largely diminished in SUMOI34E mutant. 60 | |
dc.language.iso | en | |
dc.title | BTB-kelch蛋白KLEIP類泛素化及其受質泛素化之調控分析 | zh_TW |
dc.title | SUMO Modification and SUMO Interaction of the BTB-kelch Protein KLEIP and its Function in DAPK Ubiquitination | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 呂勝春,張智芬 | |
dc.subject.keyword | 類泛素化,泛素化,轉譯後修飾, | zh_TW |
dc.subject.keyword | Sumoylation,Ubiquitination,Post-translational modification, | en |
dc.relation.page | 60 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2007-07-23 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
顯示於系所單位: | 分子醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 1.77 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。